Pulmonary Services
Pulmonary Hypertension & Pulmonary Vascular Diseases Program
Penn State Milton S. Hershey Medical Center now offers world-class care for patients with pulmonary hypertension and pulmonary vascular diseases through a comprehensive, multidisciplinary program. The team includes dedicated pulmonologists, cardiologists, interventional radiologists, and specialty nurses.
Services Offered
- Prompt diagnostic evaluation by a pulmonologist and follow up by a cardiologist, if needed.
- Diagnostic testing including right heart catheterization, acute vasoreactivity testing, stress echocardiography, and cardiopulmonary exercise testing.
- Full range of conventional and new therapies for pulmonary arterial hypertension including endothelin receptors antagonists, phosphodiestrase inhibitors, intravenous, and inhaled prostacyclin analogues.
Who May Benefit?
- High pulmonary artery pressure on echocardiogram or heart catheterization with suspected pulmonary arterial hypertension (PAH).
- Idiopathic pulmonary arterial hypertension (iPAH).
- PAH associated with:
- Rheumatological disorders, e.g. SLE, scleroderma
- Adult congenital heart disease
- Advanced liver disease and portal hypertension
- Appetite suppressant use in past
- Pulmonary thromboembolic disease
- Sickle cell disease, HIV, sarcoidosis, pulmonary, veno-occlusive disease, and others.
- Dyspnea not fully explained by pulmonary function testing or chest imaging, in the absence of suspected cardiac or neuromuscular diseases.
- Complicated chronic thromboembolic disease.
- Other pulmonary vascular diseases, e.g. symptomatic mediastinal fibrosis etc.
For more information or to schedule an appointment please call the MD Network at 1-800-233-4082.
Telephone consultations are welcomed. Call Robert Vender, M.D., at 717-531-6525.
- Prompt diagnostic evaluation by a pulmonologist and follow up by a cardiologist, if needed.
- Diagnostic testing including right heart catheterization, acute vasoreactivity testing, stress echocardiography, and cardiopulmonary exercise testing.
- Full range of conventional and new therapies for pulmonary arterial hypertension including endothelin receptors antagonists, phosphodiestrase inhibitors, intravenous, and inhaled prostacyclin analogues.
